Intelgenx Technologies's EBITDA per Share for the
three
months ended in Dec. 2023 was $-0.00.
During the past 3 years, the average EBITDA Per Share Growth Rate was 2.90% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 16.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Intelgenx Technologies was 37.70% per year. The lowest was -136.80% per year. And the median was 4.10% per year.
Competitive Comparison
For the Biotechnology subindustry, Intelgenx Technologies's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Intelgenx Technologies 5-Year EBITDA Growth Rate Distribution
For the Biotechnology industry and Healthcare sector, Intelgenx Technologies's 5-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Intelgenx Technologies's 5-Year EBITDA Growth Rate falls into.
This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.
Intelgenx Technologies 5-Year EBITDA Growth Rate Related Terms
Thank you for viewing the detailed overview of Intelgenx Technologies's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.
Intelgenx Technologies (Intelgenx Technologies) Business Description
Intelgenx Technologies Corp is an oral drug delivery company. The company is focused on the development and manufacturing of pharmaceutical oral films based on its proprietary VersaFilmTM technology platform. Intelegenx focuses on the development of novel oral immediate-release and controlled-release products for the pharmaceutical market. It offers a comprehensive portfolio of pharmaceutical services, including pharmaceutical R&D, clinical monitoring, regulatory support, tech transfer and manufacturing scale-up, and commercial manufacturing. Its geographical segments are Europe, Canada, and United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
IGXT has been successfully added to your